M Gallagher, K Quinones, RA Cervantes- … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: All children (18 years or younger) who received a BRM were assessed for
visual changes, time to control inflammation, and any associated adverse side
effects. Thirteen patients were treated with infliximab, five with ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►nih.gov S Yeh, K Wroblewski, R Buggage, Z Li, SK … - Journal of autoimmunity, 2008 - Elsevier Five patients were recruited into this non-randomized, prospective pilot study
of high-dose intravenous induction daclizumab therapy given at doses of 8 mg/kg
at day 0 and 4 mg/kg at day 14. Patients who did not meet a safety endpoint ... Cited by 4 - Related articles - All 4 versions
SM Sharma, AV Ramanan, P Riley, AD Dick - British Medical Journal, 2006 - ard.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 14 - Related articles - BL Direct - All 4 versions
SP Ardoin, D Kredich, E Rabinovich, LE … - American Journal of Ophthalmology, 2007 - Elsevier Of sixteen children (29 affected eyes) with median age 11 years, six had
associated extraocular inflammatory conditions. Fifteen of 16 were treated with
concomitant methotrexate. Median follow-up was 26 months and median ... Cited by 19 - Related articles - All 25 versions
SCB Teoh, S Sharma, A Hogan, R Lee, AV … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Chronic infantile neurological cutaneous articular (CINCA) syndrome, also known
as neonatal-onset multisystem inflammatory disease, is a rare congenital
inflammatory disease characterised by cardinal signs including a variable ... Cited by 10 - Related articles - All 4 versions
C Tappeiner, M Roesel, C Heinz, H Michels, … - Eye, 2008 - nature.com Inactivity of uveitis during the entire treatment period (mean 3.9 years) was
obtained with CsA monotherapy in 6 of 25 (24%) patients, but more often when CsA
was combined with the immunosuppressives (35/72 patients; 48.6%, P=0.037), ... Cited by 5 - Related articles - All 3 versions
- ►oxfordjournals.org G Simonini, ME Zannin, R Caputo, F Falcini, M … - Rheumatology, 2008 - Br Soc Rheumatology Methods. Fifteen patients (median age 12 yrs, range 5–21 yrs) with chronic
uveitis were enrolled. Before infliximab treatment, children had presented
active uveitis despite treatment with MTX and/or CSA. All were also ... Cited by 5 - Related articles - All 4 versions
- ►iovs.org J Plskova, K Greiner, E Muckersie, L Duncan, … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Eleven patients with refractory uveitis, and 13 healthy individuals
were enrolled. The number of circulating plasmacytoid dendritic cells (pDCs) and
their capacity to produce IFN- in culture on stimulation with synthetic ... Cited by 6 - Related articles - BL Direct - All 3 versions
C Tappeiner, C Heinz, C Specker, A … - Ophthalmic Res, 2007 - content.karger.com Background: To report on anti-CD20 antibody therapy in a patient with uveitis
refractive to immunosuppression therapy. Methods: Case report with
ophthalmoscopic, optical coherence tomography and fluorescein-angiographic ... Cited by 6 - Related articles - BL Direct - All 4 versions
